Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed 9/6/2020) Yaltormin SR 1000mg (metformin hydrochloride) Prolonged Release Tablets
Section 19A approved medicine
(Approval lapsed 9/6/2020) Yaltormin SR 1000mg (metformin hydrochloride) Prolonged Release Tablets
Section 19A approval holder
Link Medical Products Pty Ltd ABN 730 109 715 16
Phone
1800 181 060
Approved until
Status
Lapsed
Medicines in short supply/unavailable
DIABEX XR 1000 metformin hydrochloride 1000mg extended release tablet blister pack - ARTG 153699
APO-METFORMIN XR 1000 metformin hydrochloride 1000 mg modified release tablet blister pack - ARTG 281210
BLOOMS THE CHEMIST METFORMIN XR 1000 metformin hydrochloride 1000 mg modified release tablet blister pack - ARTG 278175
CHEMMART METFORMIN XR 1000 metformin hydrochloride 1000 mg modified release tablet blister pack - ARTG 278177
DIAFORMIN XR 1000 metformin hydrochloride 1000mg extended release tablet blister pack - ARTG 208441
METEX XR metformin hydrochloride 1000 mg modified release tablet blister pack - ARTG 232645
TERRY WHITE CHEMISTS METFORMIN XR 1000 metformin hydrochloride 1000 mg modified release tablet blister pack - ARTG 278179
APO-METFORMIN XR 1000 metformin hydrochloride 1000 mg modified release tablet blister pack - ARTG 281210
BLOOMS THE CHEMIST METFORMIN XR 1000 metformin hydrochloride 1000 mg modified release tablet blister pack - ARTG 278175
CHEMMART METFORMIN XR 1000 metformin hydrochloride 1000 mg modified release tablet blister pack - ARTG 278177
DIAFORMIN XR 1000 metformin hydrochloride 1000mg extended release tablet blister pack - ARTG 208441
METEX XR metformin hydrochloride 1000 mg modified release tablet blister pack - ARTG 232645
TERRY WHITE CHEMISTS METFORMIN XR 1000 metformin hydrochloride 1000 mg modified release tablet blister pack - ARTG 278179
Indication(s)
Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. Yaltormin SR may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.